These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 15173844)

  • 21. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
    Henquet C; Rosa A; Krabbendam L; Papiol S; Fananás L; Drukker M; Ramaekers JG; van Os J
    Neuropsychopharmacology; 2006 Dec; 31(12):2748-57. PubMed ID: 16936704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies.
    Ganesh S; Cortes-Briones J; Ranganathan M; Radhakrishnan R; Skosnik PD; D'Souza DC
    Int J Neuropsychopharmacol; 2020 Dec; 23(9):559-570. PubMed ID: 32385508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.
    D'Souza DC; Fridberg DJ; Skosnik PD; Williams A; Roach B; Singh N; Carbuto M; Elander J; Schnakenberg A; Pittman B; Sewell RA; Ranganathan M; Mathalon D
    Neuropsychopharmacology; 2012 Jun; 37(7):1632-46. PubMed ID: 22334121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ
    Boggs DL; Cortes-Briones JA; Surti T; Luddy C; Ranganathan M; Cahill JD; Sewell AR; D'Souza DC; Skosnik PD
    J Psychopharmacol; 2018 Dec; 32(12):1308-1318. PubMed ID: 30255720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.
    Müller-Vahl KR; Prevedel H; Theloe K; Kolbe H; Emrich HM; Schneider U
    Neuropsychopharmacology; 2003 Feb; 28(2):384-8. PubMed ID: 12589392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of THC on behavioral measures of impulsivity in humans.
    McDonald J; Schleifer L; Richards JB; de Wit H
    Neuropsychopharmacology; 2003 Jul; 28(7):1356-65. PubMed ID: 12784123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of "cannabis acute psychosis" following the administration of oral cannabis.
    Favrat B; Ménétrey A; Augsburger M; Rothuizen LE; Appenzeller M; Buclin T; Pin M; Mangin P; Giroud C
    BMC Psychiatry; 2005 Apr; 5():17. PubMed ID: 15804348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.
    Ranganathan M; Schnakenberg A; Skosnik PD; Cohen BM; Pittman B; Sewell RA; D'Souza DC
    Biol Psychiatry; 2012 Nov; 72(10):871-9. PubMed ID: 22817868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
    Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
    Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acute smoked marijuana on complex cognitive performance.
    Hart CL; van Gorp W; Haney M; Foltin RW; Fischman MW
    Neuropsychopharmacology; 2001 Nov; 25(5):757-65. PubMed ID: 11682259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC).
    Bassir Nia A; Orejarena MJ; Flynn L; Luddy C; D'Souza DC; Skosnik PD; Pittman B; Ranganathan M
    Psychopharmacology (Berl); 2022 May; 239(5):1621-1628. PubMed ID: 35438304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.
    Cortes-Briones J; Skosnik PD; Mathalon D; Cahill J; Pittman B; Williams A; Sewell RA; Ranganathan M; Roach B; Ford J; D'Souza DC
    Neuropsychopharmacology; 2015 Aug; 40(9):2124-34. PubMed ID: 25709097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation.
    Morrison PD; Stone JM
    Hum Psychopharmacol; 2011 Jan; 26(1):77-80. PubMed ID: 23055415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
    Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
    Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Δ(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques.
    Wright MJ; Vandewater SA; Parsons LH; Taffe MA
    Neuroscience; 2013 Apr; 235():51-8. PubMed ID: 23333671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.
    Stadelmann AM; Juckel G; Arning L; Gallinat J; Epplen JT; Roser P
    Neurosci Lett; 2011 May; 496(1):60-4. PubMed ID: 21513772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
    Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
    Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?
    Kleinloog D; Liem-Moolenaar M; Jacobs G; Klaassen E; de Kam M; Hijman R; van Gerven J
    J Psychopharmacol; 2012 Oct; 26(10):1307-16. PubMed ID: 22596206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.